150 related articles for article (PubMed ID: 37924202)
1. The Potential Value of Ki-67 in Prognostic Classification in Early Low-Risk Endometrial Cancer.
Jia M; Pi J; Zou J; Feng M; Chen H; Lin C; Yang S; Xiao X
Cancer Control; 2023; 30():10732748231206929. PubMed ID: 37924202
[TBL] [Abstract][Full Text] [Related]
2. The combined ratio of estrogen, progesterone, Ki-67, and P53 to predict the recurrence of endometrial cancer.
Jia M; Jiang P; Huang Z; Hu J; Deng Y; Hu Z
J Surg Oncol; 2020 Dec; 122(8):1808-1814. PubMed ID: 32920817
[TBL] [Abstract][Full Text] [Related]
3. The optimal cut-off value of immunohistochemical parameter P53 for predicting recurrence of endometrial cancer.
Jia M; Jiang P; Hu J; Huang Z; Deng Y; Hu Z
Int J Gynaecol Obstet; 2021 May; 153(2):344-350. PubMed ID: 33237570
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of P53 index in predicting the recurrence of early low-risk endometrial cancer.
Çakır İ; Gülseren V; Aköz G; Şahin Z; Sever B; Çakır ZE; Sancı M; Kuru O; Özdemir İA; Güngördük K
J Obstet Gynaecol Res; 2023 Oct; 49(10):2487-2493. PubMed ID: 37497887
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Ki67 in Patients with Stage 1-2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor.
Jiang P; Jia M; Hu J; Huang Z; Deng Y; Lai L; Ding S; Hu Z
Onco Targets Ther; 2020; 13():10841-10850. PubMed ID: 33149602
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma.
Meng Y; Quan Q; Zhang F; Liu Y; Ren S; Mu X
Front Med (Lausanne); 2021; 8():823505. PubMed ID: 35145981
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer.
Wu J; Wang R; Chen W; Wu Y; Xiao L
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():210-216. PubMed ID: 38301499
[TBL] [Abstract][Full Text] [Related]
8. Analysis of immunohistochemical characteristics and recurrence after complete remission with fertility preservation treatment in patients with endometrial carcinoma and endometrial atypical hyperplasia.
Li L; Xiao Z; Wang Y; He Y; Wang Z; Shen D; Wang J
Arch Gynecol Obstet; 2023 Jun; 307(6):2025-2031. PubMed ID: 35098335
[TBL] [Abstract][Full Text] [Related]
9. [Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial Cancer Recurrence].
Huang Z; Jiang P; Jia MZ; Li L; Deng Y; Lai L; Hu ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):489-496. PubMed ID: 34018370
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of serum CA125 levels with ER, PR, P53 and Ki-67 expression in endometrial carcinomas.
Budak E; Solakoglu Kahraman D; Budak A; Yanarateş A; Inan AH; Kanmaz AG; Beyan E
Ginekol Pol; 2019; 90(12):675-683. PubMed ID: 31909459
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer.
Li N; Jiang P; Huang Y; Tu Y; Kong W; Jiang S; Zhang J; Wu Y; Zhang X; Xie Q; Yuan R
Clin Med Insights Oncol; 2022; 16():11795549221103200. PubMed ID: 35721388
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
[TBL] [Abstract][Full Text] [Related]
15. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study.
Tashima R; Nishimura R; Osako T; Nishiyama Y; Okumura Y; Nakano M; Fujisue M; Toyozumi Y; Arima N
PLoS One; 2015; 10(7):e0119565. PubMed ID: 26177501
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the Cutoffs for HALP in Endometrial Cancer.
Wang J; Jiang P; Huang Y; Tu Y; Zhou Q; Li N; Kong W; Yuan R
Am J Clin Oncol; 2023 Mar; 46(3):107-113. PubMed ID: 36700534
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of Ki-67 according to age in patients with triple-negative breast cancer.
Zenzola V; Cabezas-Quintario MA; Arguelles M; Pérez-Fernández E; Izarzugaza Y; Correa A; García-Foncillas J
Clin Transl Oncol; 2018 Nov; 20(11):1448-1454. PubMed ID: 29671222
[TBL] [Abstract][Full Text] [Related]
20. Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas.
Hanprasertpong J; Tungsinmunkong K; Chichareon S; Wootipoom V; Geater A; Buhachat R; Boonyapipat S
J Obstet Gynaecol Res; 2010 Jun; 36(3):572-80. PubMed ID: 20598040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]